Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Propranolol Attenuates Risperidone-Induced Trabecular Bone Loss in Female Mice.

Motyl KJ, DeMambro VE, Barlow D, Olshan D, Nagano K, Baron R, Rosen CJ, Houseknecht KL.

Endocrinology. 2015 Jul;156(7):2374-83. doi: 10.1210/en.2015-1099. Epub 2015 Apr 8.

2.

Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia.

Khan MP, Singh AK, Joharapurkar AA, Yadav M, Shree S, Kumar H, Gurjar A, Mishra JS, Tiwari MC, Nagar GK, Kumar S, Ramachandran R, Sharan A, Jain MR, Trivedi AK, Maurya R, Godbole MM, Gayen JR, Sanyal S, Chattopadhyay N.

Diabetes. 2015 Jul;64(7):2609-23. doi: 10.2337/db14-1611. Epub 2015 Jan 29. Erratum in: Diabetes. 2017 Dec;66(12 ):3142-3143.

3.

PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss.

Wei W, Wang X, Yang M, Smith LC, Dechow PC, Sonoda J, Evans RM, Wan Y.

Cell Metab. 2010 Jun 9;11(6):503-16. doi: 10.1016/j.cmet.2010.04.015. Erratum in: Cell Metab. 2010 Aug 4;12(2):202. Sonoda, Junichiro [added]; Evans, Ronald M [added].

Supplemental Content

Loading ...
Support Center